Skip to main content
OpenTrials

Clinical trial condition

Inflammatory Breast Cancer (IBC)

Explore clinical trials studying Inflammatory Breast Cancer (IBC). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Inflammatory Breast Cancer (IBC) trial results

Completed

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

NCT02876302

Conditions
Breast Diseases, Breast Neoplasms, Inflammatory Breast Cancer (IBC), +6 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions